(Q33917862)

30 July 2017

1 reference

title

Onychomycosis: clinical perspective (English)

1 reference

30 July 2017

Sehgal VN

1

1 reference

PubMed ID

10809969

30 July 2017

Jain S

series ordinal

2

1 reference

30 July 2017

1 April 2000

1 reference

International Journal of Dermatology

30 July 2017

1 reference

30 July 2017

39

1 reference

30 July 2017

4

1 reference

30 July 2017

241-249

1 reference

Onychomycosis is more than a cosmetic problem

30 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00812.X

Quality of life of persons with onychomycosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00812.X

Terbinafine for the treatment of pedal onychomycosis. A foot closer to the promised land of cured nails?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00812.X

Impact of onychomycosis on quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00812.X

The effect of toenail onychomycosis on patient quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00812.X

Measuring health-related quality of life in onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00812.X

Current issues in onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00812.X

Immediate and Delayed Hypersensitivity in Chronic Dermatophytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00812.X

Human dermatophyte-responsive T-cell lines recognize cross-reactive antigens associated with mannose-rich glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00812.X

The spectrum of nail disease in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00812.X

Pharmacoeconomic analysis of oral therapies for onychomycosis: a US model

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00812.X

Taxonomy, biology, and clinical aspects of Fusarium species

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00812.X

Fatal hyalohyphomycosis following Fusarium onychomycosis in an immunocompromised patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00812.X

Histologic evaluation of nail clippings for diagnosing onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00812.X

Present and potential diagnostic techniques in onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00812.X

10.1046/J.1365-4362.2000.00812.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10809969